Volume 2, issue 6, December 2001

13 articles in this issue

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

Authors (first, second and last of 15)
- Lutgarde Thijs
- Jan A Staessen
- Robert H Fagard
- Content type: Research
- Published: 18 October 2001
- Article: 298
Biventricular pacing in heart failure: update on results from clinical trials

Authors
- Guy Haywood
- Content type: Review
- Published: 28 November 2001
- Article: 292
Distal protection devices during percutaneous coronary and carotid interventions

Authors (first, second and last of 4)
- Panayotis Fasseas
- James L Orford
- Peter B Berger
- Content type: Review
- Published: 23 November 2001
- Article: 286
Therapeutic angiogenesis for cardiovascular disease

Authors
- Yin-Shan Ng
- Patricia A D'Amore
- Content type: Review
- Published: 24 October 2001
- Article: 278
Cytokines as new treatment targets in chronic heart failure

Authors
- Jan Kristian Damås
- Lars Gullestad
- Pål Aukrust
- Content type: Review
- Published: 16 October 2001
- Article: 271
Debate: Statins should be used in patients with heart failure

Authors
- John Kjekshus
- Content type: Commentary
- Published: 28 November 2001
- Article: 268
Debate: Should statin be used in patients with heart failure?

Authors
- Aldo Pietro Maggioni
- Content type: Commentary
- Published: 27 November 2001
- Article: 266
Debate: PCI vs CABG: a moving target, but we are gaining

Authors
- David R Holmes Jr
- Content type: Commentary
- Published: 28 November 2001
- Article: 263
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight

Authors
- Deepak L Bhatt
- Eric J Topol
- Content type: Commentary
- Published: 25 October 2001
- Article: 260
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?

Authors
- Irene Gavras
- Haralambos Gavras
- Content type: Commentary
- Published: 03 November 2001
- Article: 257
Comments on ALLHAT and doxazosin

Authors
- Lawrence R Krakoff
- Content type: Commentary
- Published: 01 November 2001
- Article: 254
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

Authors
- Philip L Hooper
- Content type: Commentary
- Published: 20 September 2001
- Article: 251
A new era in hypertension research: discussing the findings of ALLHAT

Authors
- Curt D Furberg
- Content type: Editorial
- Published: 28 November 2001
- Article: 249

Volume 2, issue 6, December 2001

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

Biventricular pacing in heart failure: update on results from clinical trials

Distal protection devices during percutaneous coronary and carotid interventions

Therapeutic angiogenesis for cardiovascular disease

Cytokines as new treatment targets in chronic heart failure

Debate: Statins should be used in patients with heart failure

Debate: Should statin be used in patients with heart failure?

Debate: PCI vs CABG: a moving target, but we are gaining

Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?

Comments on ALLHAT and doxazosin

Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

A new era in hypertension research: discussing the findings of ALLHAT

For authors

Explore

Navigation

Volume 2, issue 6, December 2001

Authors (first, second and last of 15)

Authors

Authors (first, second and last of 4)

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

For authors

Explore

Search

Navigation